Octreotide oral capsule (Rani Therapeutics)

N/A

Report date: 2025/02/17 20:01:03

Base Information

Drug NameOctreotide oral capsule (Rani Therapeutics)
Drug Alias NameOctreotide-Ranipill-drug-delivery-capsule
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor agonists
TargetsSomatostatin receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNanoviricides
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRani Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeH01CB02
Related LinksN/A